Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens

Dendritic cells and the control of immunity

Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,244 · see citing works

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,090 · see citing works

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127 · see citing works

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909 · see citing works

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898 · see citing works

mRNA capping: biological functions and applications

Ramanathan, A., Robb, G. B., & Chan, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw551 · Cited by 892 · see citing works

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884 · see citing works

The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency.

Gallie, D. R. (1991) · Genes & Development · doi:10.1101/gad.5.11.2108 · Cited by 868 · see citing works

N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

Andries, O., Mc Cafferty, S., De Smedt, S. C., Weiss, R., Sanders, N. N., & Kitada, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.051 · Cited by 701 · see citing works

Advances in mRNA Vaccines for Infectious Diseases

Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 680 · see citing works

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells

Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625 · see citing works

mRNA vaccine delivery using lipid nanoparticles

Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624 · see citing works

Effect of pH and Ionic Strength on the Spectrophotometric Assessment of Nucleic Acid Purity

Wilfinger, W. W., Mackey, K., & Chomczyński, P. (1997) · BioTechniques · doi:10.2144/97223st01 · Cited by 555 · see citing works

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

Petsch, B., Schnee, M., Vogel, A. B., Lange, E., Hoffmann, B., Voss, D., Schlake, T., Thess, A., Kallen, K.-J., Stitz, L., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2436 · Cited by 461 · see citing works

Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios.

Glasel, J. A. (1995) · PubMed · Cited by 437 · see citing works

The bacterial enzyme RppH triggers messenger RNA degradation by 5′ pyrophosphate removal

Deana, A., Čelešnik, H., & Belasco, J. G. (2008) · Nature · doi:10.1038/nature06475 · Cited by 418 · see citing works

Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

Guan, S., & Rosenecker, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.5 · Cited by 389 · see citing works

XRN 5′→3′ exoribonucleases: Structure, mechanisms and functions

Nagarajan, V. K., Jones, C. I., Newbury, S. F., & Green, P. J. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.03.005 · Cited by 366 · see citing works

Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening

Orlandini von Niessen, A. G., Poleganov, M. A., Rechner, C., Plaschke, A., Kranz, L. M., Fesser, S., Diken, M., Löwer, M., Vallazza, B., Beissert, T., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.011 · Cited by 365 · see citing works

The past, present and future of cell-free protein synthesis

Katzen, F., Chang, G. A., & Kudlicki, W. A. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.01.003 · Cited by 341 · see citing works

Characterization of SYBR Gold Nucleic Acid Gel Stain: A Dye Optimized for Use with 300-nm Ultraviolet Transilluminators

Tuma, R. S., Beaudet, M. P., Jin, X., Jones, L. J., Cheung, C.-Y., Yue, S., & Singer, V. L. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.3067 · Cited by 339 · see citing works

Cytotoxicity, Mutagenicity and DNA damage by Hoechst 33342.

Durand, R. E., & Olive, P. L. (1982) · Journal of Histochemistry & Cytochemistry · doi:10.1177/30.2.7061816 · Cited by 238 · see citing works

mRNA transcript therapy

Weissman, D. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.973859 · Cited by 228 · see citing works

Rapidly produced SAM ^® vaccine against H7N9 influenza is immunogenic in mice

Hekele, A., Bertholet, S., Archer, J., Gibson, D. G., Palladino, G., Brito, L. A., Otten, G. R., Brazzoli, M., Buccato, S., Bonci, A., et al. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.54 · Cited by 226 · see citing works

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

Schnee, M., Vogel, A. B., Voss, D., Petsch, B., Baumhof, P., Kramps, T., & Stitz, L. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004746 · Cited by 212 · cited 2× · see citing works

Lipid-based mRNA vaccine delivery systems

Midoux, P., & Pichon, C. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.986104 · Cited by 209 · see citing works

Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

Probst, J., Weide, B., Scheel, B., Pichler, B. J., Hoerr, I., Rammensee, H.-G., & Pascolo, S. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302964 · Cited by 206 · see citing works

Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination

Persano, S., Guevara, M. L., Li, Z., Mai, J., Ferrari, M., Pompa, P. P., & Shen, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.019 · Cited by 187 · see citing works

Comparison of SYBR® Green I nucleic acid gel stain mutagenicity and ethidium bromide mutagenicity in the Salmonella/mammalian microsome reverse mutation assay (Ames test)

Singer, V. L., Lawlor, T. E., & Yue, S. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(98)00172-7 · Cited by 181 · see citing works

Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research

Marraco, S. A. F., Grosjean, F., Duval, A., Rosa, M., Lavanchy, C., Ashok, D., Haller, S., Otten, L., Steiner, Q., Descombes, P., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00331 · Cited by 163 · see citing works

Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway

Lorenz, C., Fotin‐Mleczek, M., Roth, G. D., Becker, C., Dam, T. C., Verdurmen, W. P. R., Brock, R. E., Probst, J., & Schlake, T. (2011) · RNA Biology · doi:10.4161/rna.8.4.15394 · Cited by 152 · see citing works

Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

Maruggi, G., Chiarot, E., Giovani, C., Buccato, S., Bonacci, S., Frigimelica, E., Margarit, I., Geall, A., Bensi, G., & Maione, D. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.11.040 · Cited by 149 · see citing works

Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides

Lukavsky, P. J., & Puglisi, J. D. (2004) · RNA · doi:10.1261/rna.5264804 · Cited by 139 · see citing works

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response

Foster, J., Choudhari, N., Perazzelli, J., Storm, J., Hofmann, T. J., Jain, P., Storm, P. B., Pardi, N., Weissman, D., Waanders, A. J., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.145 · Cited by 133 · see citing works

Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA

Zhao, M., Li, M., Zhang, Z., Gong, T., & Sun, X. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1038856 · Cited by 132 · see citing works

Nucleoside modified mRNA vaccines for infectious diseases

Pardi, N., & Weissman, D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_6 · Cited by 129 · see citing works

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

Magini, D., Giovani, C., Mangiavacchi, S., Maccari, S., Cecchi, R., Ulmer, J. B., Gregorio, E. D., Geall, A. J., Brazzoli, M., & Bertholet, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161193 · Cited by 127 · see citing works

Quantification and real-time tracking of RNA in live cells using Sticky-flares

Briley, W. E., Bondy, M. H., Randeria, P. S., Dupper, T. J., & Mirkin, C. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510581112 · Cited by 119 · see citing works

Single-cell mRNA transfection studies: Delivery, kinetics and statistics by numbers

Leonhardt, C., Schwake, G., Stögbauer, T. R., Rappl, S., Kuhr, J.-T., Ligon, T. S., & Rädler, J. O. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.11.008 · Cited by 117 · see citing works

Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines

Démoulins, T., Milona, P., Englezou, P. C., Ebensen, T., Schulze, K., Suter, R., Pichon, C., Midoux, P., Guzmán, C. A., Ruggli, N., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.11.001 · Cited by 107 · see citing works

Rapid purification of RNAs using fast performance liquid chromatography (FPLC)

Kim, I., McKenna, S. A., Puglisi, E. V., & Puglisi, J. D. (2006) · RNA · doi:10.1261/rna.342607 · Cited by 106 · see citing works

Purification and characterization of transcribed RNAs using gel filtration chromatography

McKenna, S. A., Kim, I., Puglisi, E. V., Lindhout, D. A., Aitken, C. E., Marshall, R. A., & Puglisi, J. D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.480 · Cited by 98 · see citing works

Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency

Grudzien‐Nogalska, E., Stȩpiński, J., Jankowska‐Anyszka, M., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (2004) · RNA · doi:10.1261/rna.7380904 · Cited by 97 · see citing works

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

Michiels, A., Tuyaerts, S., Bonehill, A., Corthals, J., Breckpot, K., Heirman, C., Van Meirvenne, S., Dullaers, M., Allard, S., Brasseur, F., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302471 · Cited by 93 · see citing works

Overview of Cell‐Free Protein Synthesis: Historic Landmarks, Commercial Systems, and Expanding Applications

Chong, S. (2014) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1630s108 · Cited by 93 · see citing works

Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections

Versteeg, L., Almutairi, M. M., Hotez, P. J., & Pollet, J. B. K. (2019) · Vaccines · doi:10.3390/vaccines7040122 · Cited by 93 · see citing works

Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles

Shin, H., Park, S. D., Yim, Y., Kim, J., Choi, C., Won, C., & Min, D. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800065 · Cited by 91 · see citing works

Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS

Beverly, M., Dell, A., Parmar, P., & Houghton, L. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9605-x · Cited by 83 · see citing works

Measurement of Nucleic Acid Concentrations Using the DyNA Quant™ and the GeneQuant™

Teare, J. M., Islam, R., Flanagan, R., Gallagher, S. R., Davies, M. G., & Grabau, C. (1997) · BioTechniques · doi:10.2144/97226pf02 · Cited by 81 · see citing works

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles

Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s39810 · Cited by 79 · see citing works

Cotranslational incorporation of non‐standard amino acids using cell‐free protein synthesis

Quast, R. B., Mrusek, D., Hoffmeister, C., Sonnabend, A., & Kubick, S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.041 · Cited by 77 · see citing works

Characterizing exogenous mRNA delivery, trafficking, cytoplasmic release and RNA–protein correlations at the level of single cells

Kirschman, J. L., Bhosle, S. M., Vanover, D. A., Blanchard, E. L., Loomis, K. H., Zurla, C., Murray, K. A., Lam, B. C., & Santangelo, P. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx290 · Cited by 77 · see citing works

Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles

Yasar, H., Biehl, A., Rossi, C. D., Koch, M., Murgia, X., Loretz, B., & Lehr, C. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0401-y · Cited by 77 · see citing works

Recent advances in mRNA vaccine delivery

Tan, L., & Sun, X. (2018) · Nano Research · doi:10.1007/s12274-018-2091-z · Cited by 70 · see citing works

Intracellular mRNA Regulation with Self-Assembled Locked Nucleic Acid Polymer Nanoparticles

Rush, A. M., Nelles, D. A., Blum, A. P., Barnhill, S. A., Tatro, E. T., Yeo, G. W.-M., & Gianneschi, N. C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503598z · Cited by 65 · see citing works

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins

Gulck, E. R. A. V. (2005) · Blood · doi:10.1182/blood-2005-01-0339 · Cited by 63 · see citing works

RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines

Rauch, S., Lutz, J., Kowalczyk, A., Schlake, T., & Heidenreich, R. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6481-9_5 · Cited by 57 · see citing works

Simple and practical staining of DNA with GelRed in agarose gel electrophoresis.

Huang, Q. Y., Baum, L., & Fu, W. (2010) · PubMed · Cited by 56 · see citing works

Scaffold-mediated delivery for non-viral mRNA vaccines

Chen, R., Zhang, H., Yan, J., & Bryers, J. D. (2018) · Gene Therapy · doi:10.1038/s41434-018-0040-9 · Cited by 50 · see citing works

Staining nucleic acids and proteins in electrophoresis gels

Williams, L. (2001) · Biotechnic & Histochemistry · doi:10.1080/bih.76.3.127.132 · Cited by 43 · see citing works

mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446

Bell, G. D., Yang, Y., Leung, E. Y., & Krissansen, G. W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201464 · Cited by 43 · see citing works

Stability analysis of chemically modified mRNA using micropattern-based single-cell arrays

Ferizi, M., Leonhardt, C., Meggle, C., Aneja, M. K., Rudolph, C., Plank, C., & Rädler, J. O. (2015) · Lab on a Chip · doi:10.1039/c5lc00749f · Cited by 41 · see citing works

Ultraviolet absorbance at 260 and 280 nm in RNA measurement is dependent on measurement solution.

Okamoto, T., & Okabe, S. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.5.6.657 · Cited by 39 · see citing works

Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles

McCullough, K. C., Milona, P., Thomann, L., Démoulins, T., Englezou, P. C., Suter, R., & Ruggli, N. (2014) · Vaccines · doi:10.3390/vaccines2040735 · Cited by 33 · see citing works

The European Regulatory Environment of RNA-Based Vaccines

Hinz, T., Kallen, K., Britten, C. M., Flamion, B., Granzer, U., Hoos, A., Huber, C., Khleif, S. N., Kreiter, S., Rammensee, H., et al. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_13 · Cited by 30 · see citing works

Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice

Hattinger, E., Scheiblhofer, S., Roesler, E., Thalhamer, T., Thalhamer, J., & Weiss, R. (2015) · Journal of Immunology Research · doi:10.1155/2015/797421 · Cited by 28 · see citing works

Self-Replicating RNA Vaccine Delivery to Dendritic Cells

Démoulins, T., Englezou, P. C., Milona, P., Ruggli, N., Tirelli, N., Pichon, C., Sapet, C., Ebensen, T., Guzmán, C. A., & McCullough, K. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_3 · Cited by 27 · see citing works

Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy

Chung, D. J., Romano, E., Pronschinske, K. B., Shyer, J. A., Mennecozzi, M., Angelo, E. T. S., & Young, J. W. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-166 · Cited by 23 · see citing works

Human peripheral blood monuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T-lymphocytes in vitro

Teufel, R., Carralot, J.-P., Scheel, B., Probst, J., Walter, S., Jung, G., Hoerr, I., Rammensee, H.-G., & Pascolo, S. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5067-6 · Cited by 22 · see citing works

A novel, sensitive fluorometric staining technique for the detection of DNA in RNA preparations

Mocharla, R., Mocharla, H., & Hodes, M. E. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.24.10589 · Cited by 22 · see citing works

In vitro labeling strategies for in cellulo fluorescence microscopy of single ribonucleoprotein machines

Custer, T. C., & Walter, N. G. (2016) · Protein Science · doi:10.1002/pro.3108 · Cited by 22 · see citing works

The plasticity and potential of leukemia cell lines to differentiate into dendritic cells

Guo, Q., Zhang, L., Li, F., & Jiang, G. (2012) · Oncology Letters · doi:10.3892/ol.2012.821 · Cited by 15 · see citing works

Generation of Immunostimulating 130 nm Protamine–RNA nanoparticles

Tusup, M., & Pascolo, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_9 · Cited by 15 · see citing works

Considerations for Producing mRNA Vaccines for Clinical Trials

Schmid, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_15 · Cited by 11 · see citing works

Adjuvant-Enhanced mRNA Vaccines

Bialkowski, L., der Jeught, K. V., Renmans, D., van Weijnen, A., Heirman, C., Keyaerts, M., Breckpot, K., & Thielemans, K. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_11 · Cited by 11 · see citing works

Measuring the Adjuvant Activity of RNA Vaccines

Pardi, N., & Weissman, D. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_8 · Cited by 9 · see citing works

Comparison of Agilent 2100 Bioanalyzer and Caliper Life Sciences GX II in Functionality, Total RNA Scoring Algorithms and Reproducibility to Evaluate Total RNA Integrity

Malmanger, B., Harrington, C. A., & Savage, S. L. (2012) · Europe PMC (PubMed Central) · Cited by 4 · see citing works

Characterization of optimal T Cell/Dendritic Cell (DC) Co-Culture Conditions for Ex Vivo Expansion of Antigen-Specific Human T Cells.

Komanduri, K. V., Thomas, M. W., John, L. S. S., Xing, D., Decker, W. K., Robinson, S. N., Yang, H. Y., Molldrem, J. J., Champlin, R. E., McMannis, J. D., et al. (2006) · Blood · doi:10.1182/blood.v108.11.3654.3654 · Cited by 2 · see citing works

mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability

Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

mRNA vaccines manufacturing: challenges and bottlenecks

Rosa, S. S., Prazeres, D. M. F., Azevedo, A. M., & Marques, M. P. C. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.038 · Cited by 545 · see citing works

Addressing the Cold Reality of mRNA Vaccine Stability

Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W., & Mastrobattista, E. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.12.006 · Cited by 517 · see citing works

Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity

Zhang, H., Vandesompele, J., Braeckmans, K., Smedt, S. C. D., & Remaut, K. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00194f · Cited by 140 · see citing works

Quality by Design for enabling RNA platform production processes

Daniel, S., Kis, Z., Kontoravdi, C., & Shah, N. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.03.012 · Cited by 128 · see citing works

Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections

Versteeg, L., Almutairi, M. M., Hotez, P. J., & Pollet, J. B. K. (2019) · Vaccines · doi:10.3390/vaccines7040122 · Cited by 93 · see citing works

Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation

Halamoda‐Kenzaoui, B., Vandebriel, R. J., Howarth, A., Siccardi, M., David, C. A. W., Liptrott, N. J., Santin, M., Borgos, S. E., Bremer‐Hoffmann, S., & Caputo, F. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.016 · Cited by 90 · see citing works

Stabilizing vaccines via drying: Quality by design considerations

Ghaemmaghamian, Z., Zarghami, R., Walker, G., O’Reilly, E. J., & Ziaee, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114313 · Cited by 90 · see citing works

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

Chavda, V. P., Soni, S., Vora, L. K., Soni, S., Khadela, A. D., & Ajabiya, J. (2022) · Vaccines · doi:10.3390/vaccines10122150 · Cited by 82 · see citing works

Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain

Kis, Z. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020430 · Cited by 83 · see citing works

Maximizing mRNA vaccine production with Bayesian optimization

Rosa, S. S., Nunes, D., Antunes, L., Prazeres, D. M. F., Marques, M. P. C., & Azevedo, A. M. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28216 · Cited by 70 · see citing works

mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles

Ouranidis, A., Vavilis, T., Mandala, E., Davidopoulou, C., Stamoula, Ε., Markopoulou, C. K., Karagianni, A., & Kachrimanis, K. (2021) · Biomedicines · doi:10.3390/biomedicines10010050 · Cited by 72 · see citing works

mRNA vaccine quality analysis using RNA sequencing

Gunter, H. M., Idrisoglu, S., Singh, S., Han, D. J., Ariens, E., Peters, J. R., Wong, T., Cheetham, S. W., Xu, J., Rai, S. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41354-y · Cited by 69 · see citing works

The potential of long noncoding RNA therapies

Mercer, T. R., Munro, T. P., & Mattick, J. S. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.01.008 · Cited by 71 · see citing works

Considerations for bioanalytical characterization and batch release of COVID-19 vaccines

Sanyal, G., Särnefält, A., & Kumar, A. (2021) · npj Vaccines · doi:10.1038/s41541-021-00317-4 · Cited by 57 · see citing works

Design Strategies for and Stability of mRNA–Lipid Nanoparticle COVID-19 Vaccines

Liu, T., Tian, Y., Zheng, A., & Cui, C. (2022) · Polymers · doi:10.3390/polym14194195 · Cited by 52 · see citing works

The Platform Technology Approach to mRNA Product Development and Regulation

Skerritt, J. H., Tucek, C. L., Sutton, B. A., & Nolan, T. M. (2024) · Vaccines · doi:10.3390/vaccines12050528 · Cited by 46 · see citing works

Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action

Maruggi, G., Ulmer, J. B., Rappuoli, R., & Yu, D. L. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_233 · Cited by 45 · see citing works

Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size

Shi, R., Liu, X., Wang, Y., Pan, M., Wang, S., Shi, L., & Ni, B. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2342592 · Cited by 46 · see citing works

Considerations for mRNA Product Development, Regulation and Deployment Across the Lifecycle

Skerritt, J. H. (2025) · Vaccines · doi:10.3390/vaccines13050473 · Cited by 30 · see citing works

Immunogenicity and protective efficacy induced by an mRNA vaccine encoding gD antigen against pseudorabies virus infection

Jiang, Z., Zhu, L., Cai, Y., Yan, J., Fan, Y., Lv, W., Gong, S., Yin, X., Yang, X., Sun, X., et al. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108886 · Cited by 28 · see citing works

Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations

Omidi, Y., Pourseif, M. M., Ansari, R. A., & Barar, J. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2419815 · Cited by 28 · see citing works

Quantitative and qualitative comparison of mRNA loading techniques into extracellular vesicles

Guarro, M., van Veen, S., Borrós, S., Albertazzi, L., Lecina, M., & Fornaguera, C. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118813 · Cited by 14 · see citing works

Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations

Konopka, E., Edgerton, A. O., & Kutzler, M. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584876 · Cited by 13 · see citing works

A microfluidic electrophoretic dual dynamic staining method for the identification and relative quantitation of dsRNA contaminants in mRNA vaccines

Peña, A. C. D., Li, N., Vaduva, M., Bwanali, L., & Tripathi, A. (2023) · The Analyst · doi:10.1039/d3an00281k · Cited by 12 · see citing works

Two quality and stability indicating imaged CIEF methods for mRNA vaccines

Krebs, F., Burger, U., Doerks, S., Krämer, M., & Wätzig, H. (2022) · Electrophoresis · doi:10.1002/elps.202200123 · Cited by 12 · see citing works

Comprehensive chromatographic assessment of forced degraded in vitro transcribed mRNA

Dayeh, D. M., Cika, J., Moon, Y., Henderson, S., Grandi, D. D., Fu, Y., Muthusamy, K., Palackal, N. T., Ihnat, P. M., & Pyles, E. A. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.464885 · Cited by 11 · see citing works

Functionality and translation fidelity characterization of mRNA vaccines using platform based mass spectrometry detection

Stiving, A. Q., Roose, B. W., Tubbs, C. M., Haverick, M. A., Gruber, A., Rustandi, R. R., Kuiper, J. L., Schombs, M. W., Schuessler, H. A., & Li, X. (2025) · npj Vaccines · doi:10.1038/s41541-025-01082-4 · Cited by 15 · see citing works

Investigation of the Antiviral Effects of Saussurea lappa Root Extract against SARS‐CoV‐2 Virus

Polat, H. Ü., Serhatlı, M., Ekiz, A. T., Abacı, İ., Aksoy, Ö., Çakırca, G., Teki̇n, Ş., Al‐Zendani, A. A. H., Al‐Zendani, M. A. A., Korkmaz, Ö., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200804 · Cited by 11 · see citing works

Microbes, Clinical trials, Drug Discovery, and Vaccine Development: The Current Perspectives

Kandi, V., Suvvari, T. K., Vadakedath, S., & Godishala, V. (2021) · Borneo Journal of Pharmacy · doi:10.33084/bjop.v4i4.2571 · Cited by 10 · see citing works

A convenient analytic method for gel quantification using ImageJ paired with Python or R

Tomlinson, C., Rajasekaran, A., Brochu‐Gaudreau, K., Dubois, C. M., Farmilo, A. J., Gris, P., Khatiz, A., Matthews, A., Piltonen, M., Amrani, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308297 · Cited by 9 · see citing works

Flow-NMR as a Process-Monitoring Tool for mRNA IVT Reaction

Sarkar, A., Dong, G., Quaglia-Motta, J., & Sackett, K. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.11.021 · Cited by 8 · see citing works

Analytical Performance of a Multiplexed Microarray Assay for Rapid Identification and Quantification of a Multivalent mRNA Vaccine

Gerold, M. N., Toth, E., Blair, R. H., Gao, R. Y., Nadkarni, D. V., Barua, S., Woods, J., Rowlen, K. L., & Dawson, E. D. (2024) · Vaccines · doi:10.3390/vaccines12101144 · Cited by 8 · see citing works

Lipid nanoparticles employed in mRNA-based COVID-19 vaccines: An overview of materials and processes used for development and production

Pantelić, I., Milić, J., Nikolić, I., & Savic, S. D. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-33660 · Cited by 8 · see citing works

Purification of messenger RNA directly from crude IVT using polyethylene glycol and NaCl precipitation

Royo, M. D. C. P., Arnold, T., Rodriguez, I. P., Ostrovsky, N., Al‐Jazrawe, M., Hatas, A., Tenberg, V., Myerson, A. S., & Braatz, R. D. (2025) · Process Biochemistry · doi:10.1016/j.procbio.2025.06.002 · Cited by 7 · see citing works

A Compositional Model to Predict the Aggregated Isotope Distribution for Average DNA and RNA Oligonucleotides

Agten, A., Prostko, P., Geubbelmans, M., Liu, Y., Vijlder, T. D., & Valkenborg, D. (2021) · Metabolites · doi:10.3390/metabo11060400 · Cited by 7 · see citing works

A novel in-vitro expression assay by LC/MS/MS enables multi-antigen mRNA vaccine characterization

Wang, H. L., Kajbaf, K., Gau, B. C., Dawdy, A., Edwards, R., Bare, B., Raymundo, G., Iturrizaga, J., Ernsky, C., Walker, M. S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-94616-8 · Cited by 6 · see citing works

State-of-the-art review on liposomes as versatile cancer vaccine delivery systems

Vatankhah, A., Oroojalian, F., Moghaddam, S. H., Kesharwani, P., & Sahebkar, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106975 · Cited by 7 · see citing works

mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond

Prakash, S. (2023) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-023-00849-1 · Cited by 6 · see citing works

Enabling functionality and translation fidelity characterization of mRNA-based vaccines with a platform-based, antibody-free mass spectrometry detection approachPreprint

Stiving, A. Q., Roose, B. W., Tubbs, C. M., Haverick, M. A., Gruber, A., Rustandi, R. R., Kuiper, J. L., Schombs, M. W., Schuessler, H. A., & Li, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.14.594137 · Cited by 3 · see citing works

Capillary‐Based Physicochemical Characterization of Lipid Nanoparticles

Kuzucu, E. Ü., Schittny, V., Huwyler, J., & Schwarz, M. A. (2025) · Electrophoresis · doi:10.1002/elps.70032 · Cited by 2 · see citing works

RNA-based cancer vaccines: mechanisms, clinical progress, and translational challenges

Al‐Kabariti, A. Y., Kadhim, M. A., Mousa, H. M., Jyothi, S. R., Nayak, P. P., Janney, J. B., Singh, G., & Chauhan, A. S. (2025) · Immunologic Research · doi:10.1007/s12026-025-09725-3 · Cited by 2 · see citing works

The Regulatory Evaluation of Vaccines for Human Use

Baylor, N. W. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_27 · Cited by 2 · see citing works

Roadmap to the Development of mRNA Therapeutics: From Molecule Design and Delivery Strategies to Manufacturing, Quality Control, and Regulatory Considerations

Meyer, R. A., Trabulo, S. M. D., Douthwaite, J. A., & Santos, J. L. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_1 · Cited by 2 · see citing works

An antibody-free evaluation of an mRNA COVID-19 vaccine

Branham, P. J., Cooper, H. C., Williamson, Y. M., Najjar, F. N., Sutton, W. J. H., Pierce, C. L., Barr, J. R., & Williams, T. L. (2023) · Biologicals · doi:10.1016/j.biologicals.2023.101738 · Cited by 2 · see citing works

Vaccine efficacy, safety, and regulatory controls

Hillery, A. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28934-7.00008-x · Cited by 1 · see citing works

The Role of Separation Techniques in the Analysis of mRNA Therapeutic Drug Substances and Drug Products

Vanhinsbergh, C. J. (2023) · LCGC Europe · doi:10.56530/lcgc.eu.hk6689y3 · Cited by 1 · see citing works

Validation Environment and Validation Planning

Vogel, P. U. B. (2023) · Essentials · doi:10.1007/978-3-658-38913-0_4

Generation and Characterization of In Vitro Transcribed mRNA

Poveda, C., Chen, Y., & Strych, U. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3770-8_6

Analytical Performance of a Multiplexed Microarray Assay for Rapid Identity and Quantification of a Multivalent Mrna VaccinePreprint

Gerold, M. N., Toth, E., Blair, R. H., Gao, R. Y., Nadkarni, D. V., Barua, S., Woods, J., Rowlen, K. L., & Dawson, E. D. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4849255

mRNA Vaccines: Unlocking Potential, Exploring Applications, and Envisioning Future Horizons

Mishra, G., Rathee, S., Garg, M., & Patil, U. K. (2025) · Current Drug Delivery · doi:10.2174/0115672018320938241121075859 · Cited by 1 · see citing works

Single Platform Solution for Identity and Quantification of Influenza Hemagglutinin (HA) mRNA Constructs and Resulting Expressed Proteins for Application to Influenza mRNA VaccinesPreprint

Gao, R. Y., Hu, T., Taylor, A. W., Thomas, K. N., Muramatsu, H., Pardi, N., Rowlen, K. L., & Dawson, E. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.05.704054

Establishment and Validation of a Cell-Based Relative Potency Method for Respiratory Syncytial Virus mRNA Vaccine Drug Substance

Zheng, S., Zhang, X., Li, W., & Zhao, H. (2026) · Vaccines · doi:10.3390/vaccines14050401

Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines

Patel, N., Davis, Z., Hofmann, C., Vlasak, J., Loughney, J. W., DePhillips, P. A., & Mukherjee, M. (2023) · Vaccines · doi:10.3390/vaccines11071224 · Cited by 40 · see citing works

Messenger <scp>RNA</scp>‐based vaccines: progress, challenges, applications

Kramps, T., & Probst, J. (2013) · WIREs RNA · doi:10.1002/wrna.1189 · Cited by 50 · see citing works

Preparation of Synthetic mRNAs—Overview and Considerations

Chan, S., & Roy, B. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_9 · Cited by 2 · see citing works

Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials

Whitley, J., Zwolinski, C., Denis, C., Maughan, M., Hayles, L., Clarke, D., Snare, M., Liao, H., Chiou, S., Marmura, T., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.009 · Cited by 178 · see citing works

Messenger RNA-based vaccines

Pascolo, S. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1285 · Cited by 152 · see citing works